Overview

Study to Evaluate GSK2190915 in Subjects With Mild Asthma

Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the safety and effect of repeat oral doses of GSK2190915 on lung function in mild asthmatics using a number of clinical and biological markers of efficacy.
Phase:
Phase 2
Details
Lead Sponsor:
GlaxoSmithKline